- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02223585
Gut Microbiota and Proteins Intake
Gut Microbial Response to Well-balanced Diet With Emphasis on Animal or Vegan Protein
Gut microbiota are involved in the regulation of mammalian metabolic pathways through host-microbiota metabolic, signaling, and immune-inflammatory interactions that physiologically connect the gut, liver, brain, and other organs. Correlation of these metabotypes with gut microbial profiles facilitates deciphering inherent host-microbe relationships.
Microbiome sequencing have generated novel insights into the role of gut microbial composition in health and disease, but are limited in addressing the microbial contribution to host metabolism and the gut microbial dysbiosis in disease.
This is an exploratory trial, aiming to examine how gut microbial conditions determine response to dietary challenge by measuring urine, plasma and stool metabolites resulting from metabolism of protein, polyamines and bile acids in combination with stool bacterial composition. The focus of this trial is to evaluate impact of protein based food challenges, based on cross-over design of two diet challenges of animal and vegan protein sources.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lausanne, Switzerland, 1000
- Metabolic Unit, Clinical Development Unit, Nestec
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Caucasian
- Regular bowl movement (at least once every 1-2 days)
- Between 18 and 55 years old
- BMI between 18.5 and 27 kg/m2 (inclusive)
- Willing and able to sign written informed consent prior to trial entry
Exclusion Criteria:
- Clinically relevant digestive, renal or metabolic disease, as determined by the medical (screening) visit and a standard blood chemistry analysis (glucose, total cholesterol, LDL, HDL, triglycerides, Aspartate aminotransferase (ASAT), Alanine aminotransferase (ALAT), gamma glutamyl transferase (Gamma-GT), C reactive protein (CRP), creatinine)
- Undergoing regular medical treatment, pain-killers accepted, based on the medical questionnaire
- Special diets: vegetarian, high protein or weight loss program (anamnesis)
- Pregnancy (anamnesis)
- Food allergy
- Participation in a cholesterol management program with functional foods like food supplement enriched in omega-3 fatty acids, dairy products enriched with phytosterols (margarines, yoghurts), evaluated during the medical visit
- Practicing more than 5 moderated physical activity per week
- Smoker (anamnesis)
- Have a high alcohol consumption (more than 2 drinks/day) (anamnesis)
- Consumption of illicit drugs, (anamnesis)
- Having given blood within the last month, or willing to make a blood donation until one month following the end of the study
- Subject who cannot be expected to comply with the study procedures, including consuming the test products.
- Currently participating or having participated in another clinical trial during the last month prior to the beginning of this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cross-over single arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intra-individual plasma, stools, and urine omics to acute controlled feeding
Time Frame: 3-Day baseline, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Metabonomics on fasting blood, urine, and stools and microbiota composition by 1. defining individual baseline (3-Day baseline before start of diet challenges); 2. Examining effect of the dietary challenges (3-Day diet challenge vs. Baseline); 3. Examining global dietary effect (baseline after challenge 2 vs. baseline after challenge 1) and stability of dietary effect (3rd day of each diet challenge vs. baseline after the challenge)
|
3-Day baseline, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Intra-individual plasma biochemistry response to acute controlled feeding
Time Frame: Day 1 and 3 of diet challenge 1, 1-Day baseline after challenge 1 washout, Day 1 and 3 of diet challenge 2, 1-Day baseline after challenge 2 washout
|
To evaluate effect of the dietary challenges (Day 3 vs Day1 of each diet challenge), the global dietary effect (baseline after challenge 2 vs. the baseline after challenge 1, Day 1 of diet challenge 1), stability of the dietary effect (3rd day of each diet challenge vs. baseline after the challenge)
|
Day 1 and 3 of diet challenge 1, 1-Day baseline after challenge 1 washout, Day 1 and 3 of diet challenge 2, 1-Day baseline after challenge 2 washout
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subject's omics adaptation phase to a controlled diet Subject's omics adaptation phase to a controlled diet
Time Frame: 3-Day diet challenge 1 and 2
|
Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition
|
3-Day diet challenge 1 and 2
|
Comparison of intra-individual daytime plasma response amongst diets and free living restricted diets
Time Frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition
|
3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Pairing of gut microbial metabolite to gut microbial composition to generate concept on gut functional system to be followed-up in future studies
Time Frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition
|
3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Pairing dietary intake and preferences with subjects response in Omics endpoints
Time Frame: 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition and 3- Days dietary recall during diet challenges and food frequency questionnaire at baseline before start of diet challenges
|
3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maurice Beaumont, MD, PhD, PD Dr, Metabolic Unit, Clinical Development Unit, Nestec
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 13.28.MET
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Animal-based protein diet
-
University of MinnesotaCompleted
-
University of ExeterCompleted
-
Montefiore Medical CenterThe Purjes Foundation; The Greenbaum FoundationRecruiting
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedObesity | Insulin ResistanceMexico
-
German Institute of Human NutritionUniversity Hospital Tuebingen; Ernst von Bergmann Hospital; Ministry of Food... and other collaboratorsCompletedMetabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Nutrition Disorders | Body Weight | Metabolic Syndrome xGermany
-
University of Illinois at Urbana-ChampaignNational Cattlemen's Beef AssociationRecruitingDietary Habits | Muscle Protein Synthesis | Meal FrequencyUnited States
-
Tufts UniversityCompleted
-
Jens Rikardt AndersenNutricia, Inc.; Nordsjaellands HospitalUnknownKidney Diseases | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Complications | Diabetes Mellitus, Type 1 | Glomerulonephritis | Kidney Disease, Chronic | Kidney InsufficiencyDenmark
-
Stanford UniversityRecruitingHealth BehaviorUnited States, United Kingdom
-
Essentia HealthBlue Cross Blue Shield of Michigan FoundationCompletedOsteoarthritisUnited States